- Home
- GP vs COCP Comparison
GP vs COCP Comparison
Compare GP & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GP
- COCP
- Stock Information
- Founded
- GP 2010
- COCP N/A
- Country
- GP Canada
- COCP United States
- Employees
- GP N/A
- COCP N/A
- Industry
- GP Construction/Ag Equipment/Trucks
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- GP Consumer Discretionary
- COCP Health Care
- Exchange
- GP Nasdaq
- COCP Nasdaq
- Market Cap
- GP 16.2M
- COCP 15.3M
- IPO Year
- GP 2020
- COCP N/A
- Fundamental
- Price
- GP $0.51
- COCP $1.43
- Analyst Decision
- GP Strong Buy
- COCP Strong Buy
- Analyst Count
- GP 2
- COCP 1
- Target Price
- GP $2.33
- COCP $7.00
- AVG Volume (30 Days)
- GP 78.5K
- COCP 17.0K
- Earning Date
- GP 02-14-2025
- COCP 03-31-2025
- Dividend Yield
- GP N/A
- COCP N/A
- EPS Growth
- GP N/A
- COCP N/A
- EPS
- GP N/A
- COCP N/A
- Revenue
- GP $20,656,035.00
- COCP N/A
- Revenue This Year
- GP N/A
- COCP N/A
- Revenue Next Year
- GP $94.25
- COCP N/A
- P/E Ratio
- GP N/A
- COCP N/A
- Revenue Growth
- GP N/A
- COCP N/A
- 52 Week Low
- GP $0.41
- COCP $1.35
- 52 Week High
- GP $1.91
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- GP 40.83
- COCP 34.72
- Support Level
- GP $0.41
- COCP $1.38
- Resistance Level
- GP $0.59
- COCP $1.49
- Average True Range (ATR)
- GP 0.05
- COCP 0.10
- MACD
- GP 0.00
- COCP -0.00
- Stochastic Oscillator
- GP 42.74
- COCP 12.82
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).